Difference in transcriptional regulatory function between c-Fos and Fra-2
- PMID: 1945831
- PMCID: PMC328954
- DOI: 10.1093/nar/19.20.5537
Difference in transcriptional regulatory function between c-Fos and Fra-2
Abstract
Fra-2, one of the Fos-related antigens, is promptly expressed after the growth stimulation of fibroblasts, but its induction peak is later than that of c-Fos. In this report, we examined biochemical properties of Fra-2 and compared them with those of two other Fos family proteins, c-Fos and Fra-1. Like c-Fos and Fra-1, Fra-2 formed stable heterodimers with c-Jun, JunB or JunD in vitro and all these complexes had specific DNA-binding activity to AP-1-binding sites (AP-1 sites) or related sequences. When transiently introduced into a mouse embryonic carcinoma cell line, F9, with reporter genes containing the AP-1 site from the collagenase gene, fra-2 plus c-jun suppressed the transactivation by c-jun alone. This property of Fra-2 is in clear contrast to that of c-Fos, which stimulates the transcriptional activity of c-Jun by forming a stable heterodimer. Analysis of chimeric proteins between c-Fos and Fra-2 indicated that this difference is mainly attributable to their C terminal-half regions. Interestingly, this suppressive effect of Fra-2 was not observed in the combination with JunD: fra-2 plus junD, like c-fos plus junD, had higher transcriptional activity than junD alone. Fra-1 showed essentially the same transcriptional regulatory properties as Fra-2. These differential properties greatly expand the potential range of regulatory functions of the Fos family proteins.
Similar articles
-
JunD mutants with spontaneously acquired transforming potential have enhanced transactivating activity in combination with Fra-2.Proc Natl Acad Sci U S A. 1993 Oct 15;90(20):9369-73. doi: 10.1073/pnas.90.20.9369. Proc Natl Acad Sci U S A. 1993. PMID: 8415709 Free PMC article.
-
fra-2 promoter can respond to serum-stimulation through AP-1 complexes.Oncogene. 1995 Feb 16;10(4):689-96. Oncogene. 1995. PMID: 7862446
-
Assessment of the role of activator protein-1 on transcription of the mouse steroidogenic acute regulatory protein gene.Mol Endocrinol. 2004 Mar;18(3):558-73. doi: 10.1210/me.2003-0223. Epub 2003 Dec 12. Mol Endocrinol. 2004. PMID: 14673133
-
Role of Fra-2 in cancer.Cell Death Differ. 2024 Feb;31(2):136-149. doi: 10.1038/s41418-023-01248-4. Epub 2023 Dec 16. Cell Death Differ. 2024. PMID: 38104183 Free PMC article. Review.
-
Deciphering AP-1 function in tumorigenesis: fra-ternizing on target promoters.Cell Cycle. 2007 Nov 1;6(21):2633-9. doi: 10.4161/cc.6.21.4850. Epub 2007 Aug 8. Cell Cycle. 2007. PMID: 17957143 Review.
Cited by
-
FOSL1 controls the assembly of endothelial cells into capillary tubes by direct repression of αv and β3 integrin transcription.Mol Cell Biol. 2013 Mar;33(6):1198-209. doi: 10.1128/MCB.01054-12. Epub 2013 Jan 14. Mol Cell Biol. 2013. PMID: 23319049 Free PMC article.
-
Tissue-specific transgenic knockdown of Fos-related antigen 2 (Fra-2) expression mediated by dominant negative Fra-2.Mol Cell Biol. 2001 Jun;21(11):3704-13. doi: 10.1128/MCB.21.11.3704-3713.2001. Mol Cell Biol. 2001. PMID: 11340164 Free PMC article.
-
Fra-1 induces morphological transformation and increases in vitro invasiveness and motility of epithelioid adenocarcinoma cells.Mol Cell Biol. 1998 Dec;18(12):7095-105. doi: 10.1128/MCB.18.12.7095. Mol Cell Biol. 1998. PMID: 9819396 Free PMC article.
-
A C-terminal domain in FosB, absent in FosB/SF and Fra-1, which is able to interact with the TATA binding protein, is required for altered cell growth.EMBO J. 1994 Aug 15;13(16):3832-42. doi: 10.1002/j.1460-2075.1994.tb06694.x. EMBO J. 1994. PMID: 8070410 Free PMC article.
-
JunD mutants with spontaneously acquired transforming potential have enhanced transactivating activity in combination with Fra-2.Proc Natl Acad Sci U S A. 1993 Oct 15;90(20):9369-73. doi: 10.1073/pnas.90.20.9369. Proc Natl Acad Sci U S A. 1993. PMID: 8415709 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous